Skip To Content
Back to Events
Symposium

ACD/Labs New Jersey Symposium

April 30, 2026

08:00–13:30

DoubleTree by Hilton Hotel, Westminster Room, Princeton, NJ, USA

Join us in New Jersey to hear how ACD/Labs’ technology is being used to:

  • Study macrocyclic peptidomimetic compounds and characterize their solution structure
  • Reduce the burden of experiment planning, decision-support, and data management in high throughput experimentation
  • Prepare data for AI/ML and leverage the technologies productively, today

Learn about solutions that are providing real benefits for scientists, network with colleagues and peers, and use this opportunity to provide feedback about how ACD/Labs can help address your most complex challenges with current technologies and a future Revvity Signals-integrated portfolio.

Review Agenda

Agenda

08:00
Registration & Coffee
09:00
Welcome

Scott MacDonald, Director, Strategic Accounts; ACD/Labs

09:05
NMR Spectroscopy of Unnatural Amino Acids containing Macrocyclic Peptides: Applications in Drug Discovery

Purnima Khandelwal, Scientific Associate Director, Drug Discovery Analytical, Therapeutic Discovery Sciences, Bristol Myers Squibb

09:35
High throughput experimentation-enabled predictive synthesis

Justin Diccianni, Senior Scientist, Johnson and Johnson

10:05
Coffee Break & Networking
10:45
Digitalizing Small Molecule HTE at Merck

Joe Parry , Senior Scientist Small Molecule High-Throughput Experimentation; Merck

11:15
Advancing Process Development with HTE Data and an AI-Enabled Electronic Notebook

Jason Stevens , Associate Scientific Director, Bristol Myers Squibb

11:45 - 13:30
Wrap-up & Lunch

Scott MacDonald, Director, Strategic Accounts; ACD/Labs

Load More
Hosted By

Scott MacDonald

Director, Strategic Accounts (ACD/Labs)

Katharine Lewis

Account Manager, (ACD/Labs)

Mark Meyers

Vice President, Global Sales, (ACD/Labs)

David Gosalvez

Chief Strategy Officer, (Revvity Signals)